← Back to all trials
Active Not Recruiting
NCT03495011
MRI Characterization of Mammographically Detected DCIS
Conditions: Breast Cancer, Stage 0
Sex: Female
Ages: 18 Years – 80 Years
Enrollment: 122
Sponsor: University of Washington
Location: Fred Hutch/University of Washington Cancer Consortium Seattle Washington
Summary
This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS).
The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical resection can biologically characterize this common pre-invasive malignancy, ductal carcinoma in situ (DCIS), which typically presents in asymptomatic women as suspicious calcifications on mammography.
Eligibility Criteria
Inclusion Criteria:
* \[Cohort A\] Women aged 18 or older with suspicious calcifications identified on mammography without an associated mass
* \[Cohort B\] Women aged 18 or older with recent biopsy-proven DCIS with residual calcifications present on mammogram after biopsy
Exclusion Criteria for Both Cohorts:
* Patients with prior history of breast cancer in the ipsilateral breast
* Patients with a newly diagnosed breast cancer in the contralateral breast
* Contra-indication to contrast-enhanced breast MRI (e.g. renal insufficiency with GFR\
Source: ClinicalTrials.gov (NCT03495011). StuddyBuddy aggregates publicly available trial information.